WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
Über uns UVC Partners is one of Europe’s leading early-stage venture capital firms. With our fourth fund generation of €250 million, we invest in disruptive B2B startups at the seed and Series A stage across Europe.
WHO WE ARE At Proxima Fusion, were driven by a bold mission – to redefine the future of sustainable energy. Our unique concept, built upon the groundbreaking W7-X stellarator and the latest advances in technology, paves
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
Huawei Heisenberg Research Center (Munich) is responsible for advanced technology research, architectural development, design and strategic engineering of our products. The Optical Technology Laboratory in Munich researches and develops signal processing, components, systems, and optical switching
OUR VISION When people use our technology to bridge the gap between the physical and digital worlds,they don’tjust capture reality - they create a new one. In this new reality, they aresmarter,more productive, more streamlined, and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
WHO WE ARE Proxima Fusion is Europe’s fastest-growing fusion company and the continent’s best-funded fusion player, as well as the first spin-out from the Max Planck Institute for Plasma Physics (IPP). Backed by over €650M and
Huaweis Heisenberg Research Center in Munich is responsible for advanced technology research, architectural development, design and strategic engineering of our products.Huaweis Kepler Research Center (Jena) is responsible for advanced technology research and architectural development of optics-related
School Office - Academic and Student Affairs School of Computation, Information and Technology Technische Universität München Die TUM-School of Computation, Information and Technology (CIT) ist ein wichtiger Teil der Technischen Universität München - einer der führenden europäischen Universitäten
Overview In this role you will lead a high-performing team to push breakthroughs in LCOS-based display and imaging technologies for projector light engines and related optical systems. You will shape next-generation LCOS devices, from concept to
Overview In this role you will drive AI-enabled computational pathology and multimodal biomarker programs to influence patient selection and translational decisions across Oncology and BioPharma. You will lead cross-functional teams to translate data-driven insights into clinical